Trial Profile
A Phase 1, Randomized, Double-blind, Placebo-controlled Assessment of the Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of Flufirvitide-3 Nasal Spray in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Jan 2012
Price :
$35
*
At a glance
- Drugs Flufirvitide-3 (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- 13 Jan 2012 Actual end date Jan 2012 added as reported by ClinicalTrials.gov.
- 13 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Oct 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.